[Skip to Content]
[Skip to Content Landing]
April 1969

Surgery of the ColonManagement and Complications

Author Affiliations

Rochester, Minn
From the sections of surgery (Dr. Beahrs) and medicine (Dr. Dearing), Mayo Clinic and Foundation, and the Mayo Graduate School of Medicine (University of Minnesota), Rochester (Dr. Hoehn).

Arch Surg. 1969;98(4):480-486. doi:10.1001/archsurg.1969.01340100112015

Three to four decades ago the mortality associated with colon and rectal surgery was 20% or greater and the morbidity was high. This experience earlier had led to the development of multiple-staged operations for the management of neoplastic and inflammatory diseases of the large bowel and rectum. With the introduction of chemotherapeutic agents (the sulfonamides, which were poorly absorbed in the gastrointestinal tract)1 in the late 1930's, the mortality for colon surgery promptly began to fall; and over the next decade it was reduced to approximately 5% in most reports. Shortly after the sulfonamides, antibiotics came into use and aided further the management of patients having colon surgery. Poth2,3 advocated the combined use of phthalylsulfathiazole (Sulfathalidine) and neomycin as the best prophylactic drugs for suppressing the widest number and variety of intestinal microorganisms. This combination of drugs or some modification of it has been used and recommended by

First Page Preview View Large
First page PDF preview
First page PDF preview